p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245 · see citing works

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

Nishikawa, R., Ji, X.-D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936 · see citing works

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855 · see citing works

Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724 · see citing works

Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

Cairns, P., Polascik, T. J., Eby, Y. J., Tokino, K., Califano, J. A., Merlo, A. U., Mao, L., Herath, J. F., Jenkins, R. B., Westra, W. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 626 · see citing works

E1A signaling to p53 involves the p19ARFtumor suppressorPreprint

de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C. L., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 607 · see citing works

Interaction between the retinoblastoma protein and the oncoprotein MDM2

Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J. W., Sellers, W. R., & Livingston, D. M. (1995) · Nature · doi:10.1038/375694a0 · Cited by 586 · see citing works

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., & Collins, V. P. (1993) · PubMed · Cited by 562 · see citing works

Untitled work

(1997) · PubMed · Cited by 512 · see citing works

DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours

Mollenhauer, J., Wiemann, S., Scheurlen, W. G., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A., & Poustka, A. (1997) · Nature Genetics · doi:10.1038/ng0997-32 · Cited by 446 · see citing works

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Schmidt, E., Ichimura, K., Reifenberger, G., & Collins, V. P. (1994) · PubMed · Cited by 436 · see citing works

p300/MDM2 complexes participate in MDM2-mediated p53 degradation

Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414 · see citing works

Complex structure and regulation of the P16 (MTS1) locus.

Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383 · see citing works

Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53

Zhang, Y., & Xiong, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80351-2 · Cited by 347 · see citing works

PTEN mutations in gliomas and glioneuronal tumors

Duerr, E., Rollbrocker, B., Hayashi, Y., Peters, N., Meyer‐Puttlitz, B., Louis, D. N., Schramm, J., Wiestler, O. D., Parsons, R. E., Eng, C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201756 · Cited by 345 · see citing works

A novel p16INK4A transcript.

Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329 · see citing works

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

Ichimura, K., Bondesson, M., Goike, H., Schmidt, E., Moshref, A., & Collins, V. P. (2000) · PubMed · Cited by 282 · see citing works

Molecular pathways in the formation of gliomas

von Deimling, A., Louis, D. N., & Wiestler, O. D. (1995) · Glia · doi:10.1002/glia.440150312 · Cited by 245 · see citing works

CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.

He, J., Allen, J. R., Collins, V. P., Allalunis‐Turner, M. J., Godbout, R., Day, R. S., & James, C. D. (1994) · PubMed · Cited by 217 · see citing works

Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tract

Waridel, F., Estreicher, A., Bron, L. P., Flaman, J., Fontolliet, C., Monnier, P., Frébourg, T., & Iggo, R. D. (1997) · Oncogene · doi:10.1038/sj.onc.1200812 · Cited by 179 · see citing works

Amplification and Overexpression of MDM2 in Primary (de novo) Glioblastomas

Biernat, W., Kleihues, P., Yonekawa, Y., & Ohgaki, H. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199702000-00009 · Cited by 178 · see citing works

Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas

Biernat, W., Tohma, Y., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1997) · Acta Neuropathologica · doi:10.1007/s004010050711 · Cited by 166 · see citing works

Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

Sánchez‐Céspedes, M., Reed, A. L., Buta, M. R., Li, W., Westra, W. H., Herman, J. G., Yang, S. C., Jen, J., & Sidransky, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203003 · Cited by 130 · see citing works

Association of EGFR Gene Amplification and CDKN2 (p16/MTS1) Gene Deletion in Glioblastoma Multiforme

Hayashi, Y., Ueki, K., Waha, A., Wiestler, O. D., Louis, D. N., & von Deimling, A. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00890.x · Cited by 128 · see citing works

The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.

Gazzéri, S., Della-Valle, V., Chaussade, L., Brambilla, C., Larsen, C., & Brambilla, E. M. (1998) · PubMed · Cited by 126 · see citing works

Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression

Vonlanthen, S., Heighway, J., Tschan, M. P., Borner, M., Altermatt, H. J., Каппелер, А., Tobler, A., Fey, M. F., Thatcher, N., Yarbrough, W. G., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202501 · Cited by 104 · see citing works

Determination of p53 Mutations, EGFR Overexpression, and Loss of p16 Expression in Pediatric Glioblastomas

Sure, U., Rüedi, D., Tachibana, O., Yonekawa, Y., Ohgaki, H., Kleihues, P., & Hegi, M. E. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199756070-00004 · Cited by 94 · see citing works

Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas

Maier, D., Zhang, Z., Taylor, E., Hamou, M., Gratzl, O., Meir, E. G. V., Scott, R. J., & Merlo, A. U. (1998) · Oncogene · doi:10.1038/sj.onc.1201832 · Cited by 89 · see citing works

PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas

Chiariello, E., Roz, L., Albarosa, R., Magnani, I., & Finocchiaro, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201689 · Cited by 81 · see citing works

p53 and Brain Tumors: From Gene Mutations to Gene Therapy

Fulci, G., Ishii, N., & Meir, E. G. V. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00187.x · Cited by 79 · see citing works

Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region

Nakamura, H., Yoshida, M., Tsuiki, H., Ito, K., Ueno, M., Nakao, M., Oka, K., Tada, M., Kochi, M., Kuratsu, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201618 · Cited by 67 · see citing works

Reliability of Differential PCR for the Detection of EGFR and MDM2 Gene Amplification in DNA Extracted from FFPE Glioma Tissue

HUNTER, S. B., Abbott, K. L., VARMA, V. A., Olson, J. J., Barnett, D. W., & James, C. D. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199501000-00007 · Cited by 59 · see citing works

New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26

Maier, D., Comparone, D., Taylor, E., Zhang, Z., Gratzl, O., Meir, E. G. V., Scott, R. J., & Merlo, A. U. (1997) · Oncogene · doi:10.1038/sj.onc.1201209 · Cited by 56 · see citing works

The functional role of tumor suppressor genes in gliomas

Fueyo-Margareto, J., Gomez‐Manzano, C., Yung, W. K. A., & Kyritsis, A. P. (1998) · Neurology · doi:10.1212/wnl.51.5.1250 · Cited by 39 · see citing works

Amplification of the mdm2 gene and p53 abnormalities in uterine sarcomas

Seki, A., Kodama, J., Miyagi, Y., Kamimura, S., Yoshinouchi, M., & Kudo, T. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1 · Cited by 35 · see citing works

Type and Frequency of p53 Mutations in Tumors of the Nervous System and Its Coverings

Kleihues, P., Ohgaki, H., Eibl, R. H., Reichel, M., Mariani, L., Gehring, M., Petersen, I., Holl, T. M., von Deimling, A., Wiestler, O. D., et al. (1994) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-85039-4_4 · Cited by 23 · see citing works

No Complementation Between TP53 or RB‐1 and v‐src in Astrocytomas of GFAP‐v‐src Transgenic Mice

Maddalena, A. S., Hainfellner, J. A., Hegi, M. E., Glatzel, M., & Aguzzi, A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00544.x · Cited by 20 · see citing works

Oncogenes

Benz, C. C., & Liu, E. (1989) · Cancer treatment and research · doi:10.1007/978-1-4613-1599-5 · Cited by 3 · see citing works

Glioblastoma multiforme: a review of where we have been and where we are going

Adamson, C., Kanu, O. O., Mehta, A. I., Di, C., Lin, N., Mattox, A. K., & Bigner, D. D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903052764 · Cited by 544 · see citing works

The p53 Pathway in Glioblastoma

Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440 · see citing works

Gliomagenesis: genetic alterations and mouse models

Holland, E. C. (2001) · Nature Reviews Genetics · doi:10.1038/35052535 · Cited by 453 · see citing works

The Molecular and Genetic Basis of Neurological Tumours

Zhu, Y., & Parada, L. (2002) · Nature Reviews. Cancer · doi:10.1038/nrc866 · Cited by 340 · see citing works

Recent Advances in the Treatment of Malignant Astrocytoma

Reardon, D. A., Rich, J. N., Friedman, H. S., & Bigner, D. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5302 · Cited by 308 · see citing works

Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.

Uhrbom, L., Dai, C., Celestino, J., Rosenblum, M. K., Fuller, G. N., & Holland, E. C. (2002) · PubMed · Cited by 286 · see citing works

Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets

Mao, H., LeBrun, D. G., Yang, J., Zhu, V. F., & Li, M. (2012) · Cancer Investigation · doi:10.3109/07357907.2011.630050 · Cited by 266 · see citing works

Development of novel targeted therapies in the treatment of malignant glioma

Rich, J. N., & Bigner, D. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1380 · Cited by 246 · see citing works

NFKBIA Deletion in Glioblastomas

Bredel, M., Scholtens, D. M., Yadav, A. K., Alvarez, A. A., Renfrow, J. J., Chandler, J. P., Yu, I. L. Y., Carro, M. S., Dai, F., Tagge, M. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006312 · Cited by 241 · see citing works

EGFR overexpression and radiation response in glioblastoma multiforme

Barker, F. G., Simmons, M. L., Chang, S. M., Prados, M. D., Larson, D. A., Sneed, P. K., Wara, W. M., Berger, M. S., Chen, P., Israel, M. A., et al. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01609-1 · Cited by 243 · see citing works

Naturally occurring melanomas in dogs as models for non‐ UV pathways of human melanomas

Gillard, M., Cadieu, É., Brito, C. D., Abadie, J., Vergier, B., Devauchelle, P., Degorce‐Rubiales, F., Dréano, S., Primot, A., Dorso, L., et al. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12170 · Cited by 174 · see citing works

Glioblastoma multiforme: a review of therapeutic targets

Kanu, O. O., Mehta, A. I., Di, C., Lin, N., Bortoff, K., Bigner, D. D., Yan, H., & Adamson, D. C. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902942348 · Cited by 169 · see citing works

Glioblastoma Multiforme Oncogenomics and Signaling Pathways

Kanu, O. O., Hughes, B. D., Di, C., Lin, N., Fu, J., Bigner, D. D., Yan, H., & Adamson, C. (2009) · Clinical medicine Oncology · doi:10.4137/cmo.s1008 · Cited by 146 · see citing works

Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells.

Cobbs, C., Whisenhunt, T. R., Wesemann, D. R., Harkins, L. E., Meir, E. G. V., & Samanta, M. (2003) · PubMed · Cited by 144 · see citing works

Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3

Aziz, M. H., Shen, H., & Maki, C. G. (2011) · Oncogene · doi:10.1038/onc.2011.185 · Cited by 131 · see citing works

Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth

Landen, J. W., Hau, V. S., Wang, M., Davis, T. P., Ciliax, B. J., Wainer, B. H., Meir, E. G. V., Glass, J. D., Joshi, H. C., & Archer, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0360 · Cited by 130 · see citing works

INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas

Tannapfel, A., Busse, C., Weinans, L., Benicke, M., Katalinic, A., Geißler, F., Hauss, J., & Wittekind, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204902 · Cited by 129 · see citing works

The Arf/p53 Pathway in Cancer and Aging

Matheu, A., Maraver, A., & Serrano, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6851 · Cited by 129 · see citing works

Distinct methylation profiles of glioma subtypes

Uhlmann, K., Rohde, K., Zeller, C., Szymaś, J., Vogel, S., Marczinek, K., Thiel, G., Nürnberg, P., & Laird, P. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11175 · Cited by 114 · see citing works

Genetic and epigenetic alterations as hallmarks of the intricate road to cancer

Macaluso, M., Paggi, M. G., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206955 · Cited by 109 · see citing works

Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas.

Chakravarti, A., Delaney, M. A., Noll, E., Black, P. M., Loeffler, J. S., Muzikansky, A., & Dyson, N. J. (2001) · PubMed · Cited by 111 · see citing works

The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.

Calogero, A., Arcella, A., Gregorio, G. D., Porcellini, A., Mercola, D., Liu, C., Lombari, V., Zani, M., Giannini, G., Gagliardi, F., et al. (2001) · PubMed · Cited by 109 · see citing works

Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms

Silva, J., Silva, J. M., Domínguez, G., García, J. M., Cantos, B., Rodríguez, R., Larrondo, F. J., Provencio, M., España, P., & Bonilla, F. (2003) · The Journal of Pathology · doi:10.1002/path.1297 · Cited by 107 · see citing works

TP53 promoter methylation in human gliomas

Amatya, V. J., Naumann, U., Weller, M., & Ohgaki, H. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1041-5 · Cited by 99 · see citing works

Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation

Brat, D. J., Castellano-Sanchez, A. A., Kaur, B., & Meir, E. G. V. (2002) · Advances in Anatomic Pathology · doi:10.1097/00125480-200201000-00004 · Cited by 96 · see citing works

Oligodendroglial Tumors Frequently Demonstrate Hypermethylation of theCDKN2A(MTS1, p16INK4a),p14ARF, andCDKN2B(MTS2,p15INK4b) Tumor Suppressor Genes

Wolter, M., REIFENBERGER, J., Blaschke, B., Ichimura, K., Schmidt, E., Collins, V. P., & Reifenberger, G. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.12.1170 · Cited by 97 · see citing works

Neoplastic cells are a rare component in human glioblastoma microvasculature

Rodríguez, F. J., Orr, B. A., Ligon, K. L., & Eberhart, C. G. (2012) · Oncotarget · doi:10.18632/oncotarget.427 · Cited by 86 · see citing works

Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors

Domínguez, G., Silva, J., Garcia, J. M., Silva, J. M., Rodríguez, R., Muñoz, C., Chacón, I., Sanchez, R., Carballido, J., Colás, A., et al. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(03)00133-7 · Cited by 85 · see citing works

Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma

Calogero, A., Lombari, V., Gregorio, G. D., Porcellini, A., Ucci, S., Arcella, A., Caruso, R., Gagliardi, F. M., Gulino, A., Lanzetta, G., et al. (2004) · Cancer Cell International · doi:10.1186/1475-2867-4-1 · Cited by 85 · see citing works

Modulation of Cell Cycle Components by Epigenetic and Genetic Events

Macaluso, M., Montanari, M., Cinti, C., & Giordano, A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.009 · Cited by 83 · see citing works

The INK4A/ARF Locus: Role in Cell Cycle Control and Apoptosis and Implications for Glioma Growth

Ivanchuk, S. M., Mondal, S., Dirks, P. B., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010632309113 · Cited by 80 · see citing works

Genetic modulation of hypoxia induced gene expression and angiogenesis relevance to brain tumors

Brat, D. J. (2003) · Frontiers in bioscience · doi:10.2741/942 · Cited by 77 · see citing works

Immunohistochemical Markers for Prognosis of Ependymal Neoplasms

Korshunov, A., Голанов, А. В., & Timirgaz, V. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1016222202230 · Cited by 75 · see citing works

Array Comparative Genomic Hybridization Identifies Genetic Subgroups in Grade 4 Human Astrocytoma

Misra, A., Pellarin, M., Nigro, J. M., Smirnov, I. V., Moore, D. H., Lamborn, K. R., Pinkel, D., Albertson, D. G., & Feuerstein, B. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0708 · Cited by 73 · see citing works

P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3

Zerrouqi, A., Pyrzynska, B., Febbraio, M., Brat, D. J., & Van Meir, E. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38596 · Cited by 70 · see citing works

The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma

Frank, A. J., Hernán, R., Hollander, A. B., Lindsey, J. C., Lusher, M. E., Fuller, C. E., Clifford, S. C., & Gilbertson, R. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.016 · Cited by 68 · see citing works

Genes and pathways driving glioblastomas in humans and murine disease models

Merlo, A. U. (2003) · Neurosurgical Review · doi:10.1007/s10143-003-0267-8 · Cited by 67 · see citing works

Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomas

Labuhn, M., Jones, G., Speel, E. M., Maier, D., Zweifel, C., Gratzl, O., Meir, E. G. V., Hegi, M. E., & Merlo, A. U. (2001) · Oncogene · doi:10.1038/sj.onc.1204197 · Cited by 66 · see citing works

p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways

Sánchez‐Aguilera, A., Sánchez‐Beato, M., García, J. F., Priéto, I., Pollán, M., & Piris, M. A. (2002) · Blood · doi:10.1182/blood.v99.4.1411 · Cited by 62 · see citing works

TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation

Puduvalli, V. K., Sampath, D., Bruner, J. M., Nangia, J. R., Xu, R., & Kyritsis, A. P. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6078-3 · Cited by 60 · see citing works

A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer

Hoenerhoff, M. J., Hong, H. H., Ton, T.-V., Lahousse, S. A., & Sills, R. C. (2009) · Toxicologic Pathology · doi:10.1177/0192623309351726 · Cited by 58 · see citing works

Structural mutation analysis of PTEN and its genotype‐phenotype correlations in endometriosis and cancer

Smith, I. N., & Briggs, J. M. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25105 · Cited by 55 · see citing works

Frequent LOH at Chromosome 12q22‐23 and Apaf‐1 Inactivation in Glioblastoma

Watanabe, T., Hirota, Y., Arakawa, Y., Fujisawa, H., Tachibana, O., Hasegawa, M., Yamashita, J., & Hayashi, Y. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00474.x · Cited by 55 · see citing works

Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.

Nicholson, S. A., Okby, N. T., Ma, K., Welsh, J. A., McMenamin, M. G., Travis, W. D., Jett, J. R., Tazelaar, H. D., Trastek, V. F., Pairolero, P. C., et al. (2001) · PubMed · Cited by 53 · see citing works

Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr

Fedrigo, C. A., Grivicich, I., Schunemann, D. P., Chemale, I. M., dos Santos, D., Jacovas, T., Boschetti, P. S., Jotz, G. P., Filho, A. B., & da Rocha, A. B. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-156 · Cited by 52 · see citing works

Intratumoral Spread and Increased Efficacy of a p53-VP22 Fusion Protein Expressed by a Recombinant Adenovirus

Wills, K. N., Atencio, I. A., Avanzini, J. B., Neuteboom, S., Phelan, A., Philopena, J. M., Sutjipto, S., Vaillancourt, M. T., Wen, S. F., Ralston, R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8733-8741.2001 · Cited by 52 · see citing works

The status of gene therapy for brain tumors

Fulci, G., & Chiocca, E. A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.2.197 · Cited by 51 · see citing works

Therapeutic Targets in the ARF Tumor Suppressor Pathway

Saporita, A. J., Maggi, L. B., Apicelli, A. J., & Weber, J. D. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058869 · Cited by 49 · see citing works

Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy

Shchors, K., Persson, A. I., Rostker, F., Tihan, T., Lyubynska, N., Li, N., Swigart, L. B., Berger, M. S., Hanahan, D., Weiss, W. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219142110 · Cited by 48 · see citing works

Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.

Watanabe, T., Katayama, Y., Yoshino, A., Komine, C., & Yokoyama, T. (2003) · PubMed · Cited by 46 · see citing works

Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme

Kamiryo, T., Tada, K., Shiraishi, S., Shinojima, N., Nakamura, H., Kochi, M., Kuratsu, J., Saya, H., & Ushio, Y. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.96.5.0815 · Cited by 46 · see citing works

Central nervous system

Adamson, D. C., Rasheed, B. A., McLendon, R. E., & Bigner, D. D. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0177 · Cited by 45 · see citing works

Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control

Hasan, M. K., Yaguchi, T., MINODA, Y., Hirano, T., Taira, K., Wadhwa, R., & Kaul, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040337 · Cited by 44 · see citing works

Astrocyte Differentiation States and Glioma Formation

Dai, C., & Holland, E. C. (2003) · The Cancer Journal · doi:10.1097/00130404-200303000-00002 · Cited by 45 · see citing works

Integrins and p53 pathways in glioblastoma resistance to temozolomide

Martin, S., Janoušková, H., & Dontenwill, M. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00157 · Cited by 43 · see citing works

Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver

Weihrauch, M., Markwarth, A., Lehnert, G., Wittekind, C., Wrbitzky, R., & Tannapfel, A. (2002) · Human Pathology · doi:10.1053/hupa.2002.126880 · Cited by 44 · see citing works

Molecular biology of gliomas

Lassman, A. B. (2004) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-004-0043-3 · Cited by 44 · see citing works

Genetic analysis of a multifocal glioblastoma multiforme: A suitable tool to gain new aspects in glioma development

Krex, D., Mohr, B., Appelt, H., Schackert, H. K., & Schackert, G. (2003) · Neurosurgery · doi:10.1227/01.neu.0000093426.29236.86 · Cited by 42 · see citing works

Activation of endogenous p53 by combined p19Arf gene transfer and nutlin-3 drug treatment modalities in the murine cell lines B16 and C6

Merkel, C. A., Soares, R. B. D. S., de Carvalho, A. C. V., Zanatta, D. B., Bajgelman, M. C., Fratini, P., Costanzi-Strauss, E., & Strauss, B. E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-316 · Cited by 43 · see citing works

Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma

Bradley, G., Irish, J., MacMillan, C., Mancer, K., Witterick, I., Hartwick, W. J., Gullane, P. J., Kamel‐Reid, S., & Benchimol, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204131 · Cited by 41 · see citing works

Applications of mouse glioma models in preclinical trials

Hu, X., & Holland, E. C. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.08.023 · Cited by 40 · see citing works

Correlation of molecular genetic analysis of P53 MDM2 P16 PTEN and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma

Ushio, Y. (2003) · Frontiers in bioscience · doi:10.2741/865 · Cited by 41 · see citing works

PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma

Khalid, A., Hussain, T., Manzoor, S., Saalim, M., & Khaliq, S. (2017) · Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · doi:10.1177/1010428317705754 · Cited by 42 · see citing works

Oncolytic viruses for the therapy of brain tumors and other solid malignancies a review

Chiocca, E. A. (2003) · Frontiers in bioscience · doi:10.2741/976 · Cited by 38 · see citing works

INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck

Weber, A., Bellmann, U., Bootz, F., Wittekind, C., & Tannapfel, A. (2002) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-002-0637-6 · Cited by 37 · see citing works

Genetic and Epigenetic Alterations of 9p21 Gene Products in Benign and Malignant Tumors of the Head and Neck

Weber, A., Wittekind, C., & Tannapfel, A. (2003) · Pathology - Research and Practice · doi:10.1078/0344-0338-00435 · Cited by 37 · see citing works

Heme Oxygenase-1 in Central Nervous System Malignancies

Sferrazzo, G., Rosa, M. D., Barone, E., Volti, G. L., Musso, N., Tibullo, D., & Barbagallo, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051562 · Cited by 36 · see citing works

p15 promoter methylation - A novel prognostic marker in glioblastoma patients

Urbschat (2009) · International Journal of Oncology · doi:10.3892/ijo_00000305 · Cited by 36 · see citing works

Gliomas: advances in molecular analysis and characterization

Boudreau, C. R., Yang, I., & Liau, L. M. (2005) · Surgical Neurology · doi:10.1016/j.surneu.2005.03.033 · Cited by 34 · see citing works

Genetically engineered mouse models of astrocytoma: GEMs in the rough?

Reilly, K. M., & Jacks, T. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0375 · Cited by 33 · see citing works

Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas

Ranuncolo, S. M., Varela, M. S., Morandi, A., Lastiri, J. M., Christiansen, S. B., Joffé, E. B. D. K., Pallotta, M. G., & Puricelli, L. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000027741.19213.99 · Cited by 32 · see citing works

The future role of personalized medicine in the treatment of glioblastoma multiforme

Adamson, C. (2010) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s6852 · Cited by 31 · see citing works

p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases

Korshunov, A., Голанов, А. В., & Timirgaz, V. (2001) · Acta Neuropathologica · doi:10.1007/s004010100379 · Cited by 31 · see citing works

Glioma models

Dai, C., & Holland, E. C. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00027-0 · Cited by 31 · see citing works

A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins

Wadhwa, R., Sugihara, T., Hasan, M. K., Taira, K., Reddel, R. R., & Kaul, S. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203222200 · Cited by 31 · see citing works

Alterations of p53, BCL‐2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas

Hussein, M. R., Ghorori, R. M. H. E., & El-Rahman, Y. G. A. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00482.x · Cited by 28 · see citing works

Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis

Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26 · see citing works

The Failure in the Stabilization of Glioblastoma-Derived Cell Lines: Spontaneous In Vitro Senescence as the Main Culprit

Stoczyńska-Fidelus, E., Piaskowski, S., Bieńkowski, M., Banaszczyk, M., Hułas-Bigoszewska, K., Winiecka-Klimek, M., Radomiak-Załuska, A., Och, W., Borowiec, M., Zięba, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087136 · Cited by 27 · see citing works

MDM2 mRNA Expression in the p53 Pathway May Predict the Potential of Invasion and Liver Metastasis in Colorectal Cancer

Kondo, I., Iida, S., Takagi, Y., & Sugihara, K. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9382-5 · Cited by 27 · see citing works

Brain tumors: molecular biology and targeted therapies

Hegi, M. E., Murat, A., Lambiv, W. L., & Stupp, R. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl259 · Cited by 27 · see citing works

Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors

Tam, A. S. M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.121 · Cited by 27 · see citing works

Loss of p19Arf Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms

Ulanet, D., & Hanahan, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012454 · Cited by 26 · see citing works

E2F activity is essential for survival of Myc-overexpressing human cancer cells

Santoni‐Rugiu, E., Duro, D., Farkas, T., Mathiasen, I. S., Jäättelä, M., Bártek, J., & Lukas, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205828 · Cited by 24 · see citing works

Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets

Ghimenti, C., Fiano, V., Chiadò-Piat, L., Chiò, A., Cavalla, P., & Schiffer, D. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022127302008 · Cited by 21 · see citing works

Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.

Ito, S., Ohga, T., Saeki, H., Watanabe, M., Kakeji, Y., Morita, M., Yamada, T., & Maehara, Y. (2007) · PubMed · Cited by 21 · see citing works

Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme

Ramaiah, M. J., Adusumilli, K., Chamarthy, S., & Angirekula, H. S. R. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01234-2 · Cited by 20 · see citing works

Growth suppression by a p14ARF exon 1β adenovirus in human tumor cell lines of varying p53 and Rb status

Saadatmandi, N., Tyler, T., Huang, Y., Haghighi, A. P., Frost, G., Borgström, P., & Gjerset, R. A. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700505 · Cited by 20 · see citing works

Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer

Chen, A. Y., Shih, S., Garriques, L. N., Rothenberg, M. L., Hsiao, M., & Curran, D. P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.317.4.2 · Cited by 19 · see citing works

INK4a-ARF alterations in liver cell adenoma

Tannapfel, A., Busse, C., Geiβler, F., Witzigmann, H., Hauss, J., & Wittekind, C. (2002) · Gut · doi:10.1136/gut.51.2.253 · Cited by 19 · see citing works

Molecular genetic analysis of deep-seated glioblastomas

Hayashi, Y., Yamashita, J., & Watanabe, T. (2004) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2003.12.010 · Cited by 18 · see citing works

Molecular genetic and proteomic analysis of synchronous malignant gliomas

Zhuang, Z., Lee, Y.-S., Zeng, W., Furuta, M., Vályi-Nagy, T., Johnson, M. D., Vnencak-Jones, C. L., Woltjer, R. L., & Weil, R. J. (2004) · Neurology · doi:10.1212/wnl.62.12.2316 · Cited by 17 · see citing works

Genomic destabilization and its associated mutagenesis increase with senescence‐associated phenotype expression

Yoshioka, K., & Matsuno, Y. (2020) · Cancer Science · doi:10.1111/cas.14746 · Cited by 15 · see citing works

Towards MIB-1 and p53 detection in glioma magnetic resonance image: a novel computational image analysis method

Liu, C., Zhang, H., Pan, Y., Huang, F., & Xia, S. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/24/8393 · Cited by 15 · see citing works

Wip1 over‐expression correlated with TP53/p14ARF pathway disruption in human astrocytomas

Wang, P., Rao, J., Yang, H., Zhao, H., & Yang, L. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.22004 · Cited by 14 · see citing works

Evaluation of genetic alterations in cancer-related genes in lung and brain tumors from B6C3F1 mice exposed to 1,3-butadiene or chloroprene

Ton, T.-V. T., Hong, H. L., Devereux, T. R., Melnick, R. L., Sills, R. C., & Kim, Y. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.04.015 · Cited by 13 · see citing works

Delivery systems and molecular targets of mechanism-based therapies for GBM

Phuphanich, S., Brat, D. J., & Olson, J. J. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.4.649 · Cited by 12 · see citing works

Wild type p53-dependent transcriptional upregulation of cathepsin L expression is mediated by C/EBPα in human glioblastoma cells

Katara, R., Mir, R. A., Shukla, A. A., Tiwari, A., Singh, N., & Chauhan, S. S. (2010) · Biological Chemistry · doi:10.1515/bc.2010.103 · Cited by 12 · see citing works

KUB3 amplification and overexpression in human gliomas

Fischer, U., Hemmer, D., Heckel, D., Michel, A., Feiden, W., Steudel, W.-I., Hulsebos, T. J. M., & Meese, E. U. (2001) · Glia · doi:10.1002/glia.1090 · Cited by 12 · see citing works

Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant

Klein, M. A., Rüedi, D., Nozaki, M., Dell, E. W., Diserens, A., Seelentag, W. K. F., Janzer, R. C., Aguzzi, A., & Hegi, M. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203941 · Cited by 11 · see citing works

Genetic Alterations in Brain Tumors Following 1,3-Butadiene Exposure in B6C3F1 Mice

Kim, Y., Hong, H. L., Lachat, Y., Clayton, N. P., Devereux, T. R., Melnick, R. L., Hegi, M. E., & Sills, R. C. (2005) · Toxicologic Pathology · doi:10.1080/01926230590922848 · Cited by 11 · see citing works

Deregulation of the p14ARF/Mdm2/p53 pathway and G1/S transition in two glioblastoma sets

Ghimenti, C., Fiano, V., Chiadò-Piat, L., Chiò, A., Cavalla, P., & Schiffer, D. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022127302008 · Cited by 21 · see citing works

p14ARF Deletion and Methylation in Genetic Pathways to Glioblastomas

Nakamura, M., Watanabe, T., Klangby, U., Asker, C., Wiman, K. G., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00388.x · Cited by 237 · see citing works

Study on the expression and relationship of p14~(ARF) protein and p53 protein in human glioma

Tian, X. (2010) · Proceeding of Clinical Medicine

Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation

Robertson, L. B., Armstrong, G., Olver, B. D., Lloyd, A. L., Shete, S. S., Lau, C. C., Claus, E. B., Barnholtz‐Sloan, J. S., Lai, R., Il’yasova, D., et al. (2010) · Familial Cancer · doi:10.1007/s10689-010-9346-5 · Cited by 28 · see citing works

Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas

Newcomb, E. W., Alonso, M., Sung, T., & Miller, D. C. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80207-5 · Cited by 73 · see citing works